Evaluating the brain renin‐angiotensin system (RAS) and sex differences in pre‐clinical models of Alzheimer’s Disease

Elizabeth Paronett,Hannah Smith,Zhe Yu,Laxmi Iyer,Amy R Dunn,Catherine C. Kaczorowski,Paul Marvar

DOI: https://doi.org/10.1002/alz.063318

2023-06-01

Abstract:Hypertension is linked to Alzheimer’s Disease (AD) risk, although the mechanisms remain unclear. The renin angiotensin system (RAS), critical for blood pressure homeostasis, is thought to contribute to AD pathology, and targeted RAS therapies are under current clinical investigation. To further evaluate the neurobiological mechanisms of RAS in AD, the current study leveraged two transgenic AD mouse models to compare the behavioral and cognitive deficits and the brain RAS in male and female mice. A triple‐transgenic mouse model of AD (3xTg‐AD), which exhibits both amyloid beta and tau pathology, was used for in‐house assays, while an RNA‐sequencing database using a novel mouse model on a genetically diverse background (AD‐BXD) (GEO accession number GSE119215) was used to compare expression levels of hippocampal RAS genes at 6 and 14 mos. Morris water maze (MWM) and Y‐maze alternation tests were performed at early (3‐4 mos) and middle (5‐6 mos) time points on 3xTg‐AD mice (n = 8/sex/age/genotype), followed by collection of plasma and whole brain. Compared to controls, beginning at 3.5 months, 3xTg‐AD male and female mice exhibited deficits in learning assessed by MWM escape latency (p<0.01). However, beginning at 6 months, only 3xTg‐AD females had deficits in memory assessed by Y‐maze alternation below 50% (i.e. chance) (p<0.05). Sex‐dependent deficits are consistent with variability in phenotype beginning at early time points. Next we assessed hippocampal RNA‐sequencing data from the AD‐BXD database. These data demonstrated a sex‐dependent increase in expression of counter‐regulatory RAS genes ACE (p<0.0001) and ACE2 (p<0.05) and decrease in MasR (p<0.01) when comparing 6 and 14 month females, as compared to males and wild‐type controls. There was no change in classical RAS gene expression, indicating that variation in expression of neuroprotective but not classical RAS genes may be more pronounced in aging female mice. Our results demonstrate sex and stage‐specific behavioral deficits in the 3xTg‐AD model, which may be linked to changes in hippocampal regulation of the counter‐regulatory arm of brain RAS. Additional studies are needed to further evaluate underlying mechanisms for the role of the neuroprotective arm of the brain RAS in AD and its biomarker and therapeutic targeting potential.

clinical neurology